< News, Press, & Events

Press Release

LifeMap Sciences and Genomenon Partner to Integrate Mastermind Genomic Search Engine into GeneCards Suite and TGex

LifeMap Sciences and Genomenon Partner toIntegrate Mastermind Genomic Search Engine intoGeneCards Suite and TGex

Integrations will Improve Genetic Disease Diagnosis and Coverage of Meaningful Literature

ALAMEDA, CA and ANN ARBOR, MI; April 2, 2019 -- LifeMap Sciences, the leading integrated biomedical knowledgebase company and a leading provider of tertiary NGS analysis and interpretation solutions for genetic disorders, and Genomenon, the leading genomic search company, announced today that they have entered into a partnership to improve LifeMap’sGeneCards knowledgebase and provide accelerated interpretation of genetic disorders by integrating the Mastermind Genomic Search Engine.

LifeMap’s GeneCards Knowledgebase Suite, which includes GeneCards, the Human GeneDatabase, offers detailed, comprehensive and user-friendly information on all annotated and predicted human genes. Together with other biomedical databases offered by LifeMapSciences, it caters to more than 4 million researchers world-wide and is used by more than3,000 commercial and research institutions, including top biotech pharma. GeneCards is developed at the Weizmann Institute of Science in Israel. The integration with Mastermind will enable researchers on the platform to better identify literature associated with genes, diseases and variants.

LifeMap’s TGex is a powerful platform for the management of clinical genomics workflows. It is the solution of choice for pediatric and maternal hospitals around the world, including Bambino Gesù, the largest pediatric research center in Italy, and top tier pediatric hospitals in China andHong Kong. TGex is also used by mainstream sequencing companies such as Novogene Tianjin Medical Laboratory in China. The addition of Mastermind to TGex will enable customers to better evaluate the clinical importance of variants and to assess relevant literature for validation and diagnosis directly from TGex’s user interface.

“We are continuously seeking partnerships that will strengthen the power of our knowledgebases and provide better value to our research and clinical user base. Mastermind’s comprehensive coverage of literature will add an important layer of information to theGeneCards Suite”, said Yaron Guan Golan, CEO of LifeMap Sciences, “In addition, we believe that Mastermind’s powerful literature search capabilities could significantly improve our clinical customers’ diagnosis yields, which is what we continuously strive for.”

“This partnership puts the insight from millions of genomic research publications into the hands of TGex users to accelerate patient diagnosis and ensure that nothing has been missed in making patient treatment decisions.” said Mike Klein, CEO of Genomenon. “Together withLifeMap Sciences, we’re also expanding the insight for researchers by linking genomic search results directly into the GeneCards platform, making it easier to find any publication covering the disease, gene and variants of interest.”

Genomenon will be demonstrating the integration at the ACMG Annual Clinical Genomics Meeting conference taking place in Seattle, Washington April 2-6, 2019.


Genomenon is a genomics intelligence company dedicated to improving the quality of life of genetic disease and cancer patients by making genomic information actionable. Blending the power of AI with the precision of genomic expertise, the company empowers pharmaceutical companies and the clinical diagnostic community with empirical genomic evidence and insights that both support the development of novel therapeutics and speed diagnostic assessments and treatment recommendations.

LifeMap Sciences

LifeMap Sciences is a life sciences technology company that offers integrated, streamlined solutions empowering life scientists worldwide in conducting cutting-edge basic, clinical and applied biomedical research. LifeMap’s products are used in more than 3,000 institutions including academia, research hospitals, patent offices, and leading biopharma and diagnostic companies. Operations worldwide are carried out from our offices in California, Massachusetts,New Jersey, Tel Aviv, and Hong Kong.

Read the Article
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.